Tags

Type your tag names separated by a space and hit enter

Probiotics and prebiotics in Crohn's disease therapies.

Abstract

Therapeutic manipulation of gut microbiota has proven valuable in the management of ulcerative colitis and pouchitis. Despite some similarities among the various inflammatory bowel conditions, the probiotics investigated thus far seem to confer little benefit in Crohn's disease. In this review, we aim to bring together the evidence available on the clinical effect of probiotics and prebioltics in Crohn's disease patients, and to clarify the place of probiotic treatment in current Crohn's therapeutic regimens.

Authors+Show Affiliations

Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, University of Tel Aviv, Israel. Electronic address: levl@clalit.org.il.Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, University of Tel Aviv, Israel.Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, University of Tel Aviv, Israel.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

27048899

Citation

Lichtenstein, Lev, et al. "Probiotics and Prebiotics in Crohn's Disease Therapies." Best Practice & Research. Clinical Gastroenterology, vol. 30, no. 1, 2016, pp. 81-8.
Lichtenstein L, Avni-Biron I, Ben-Bassat O. Probiotics and prebiotics in Crohn's disease therapies. Best Pract Res Clin Gastroenterol. 2016;30(1):81-8.
Lichtenstein, L., Avni-Biron, I., & Ben-Bassat, O. (2016). Probiotics and prebiotics in Crohn's disease therapies. Best Practice & Research. Clinical Gastroenterology, 30(1), pp. 81-8. doi:10.1016/j.bpg.2016.02.002.
Lichtenstein L, Avni-Biron I, Ben-Bassat O. Probiotics and Prebiotics in Crohn's Disease Therapies. Best Pract Res Clin Gastroenterol. 2016;30(1):81-8. PubMed PMID: 27048899.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Probiotics and prebiotics in Crohn's disease therapies. AU - Lichtenstein,Lev, AU - Avni-Biron,Irit, AU - Ben-Bassat,Ofer, Y1 - 2016/02/09/ PY - 2016/01/22/received PY - 2016/01/29/revised PY - 2016/02/02/accepted PY - 2016/4/7/entrez PY - 2016/4/7/pubmed PY - 2016/9/23/medline KW - Bifidobacterium KW - Crohn's disease KW - Inflammatory bowel disease KW - Lactobacillus KW - Prebiotics KW - Probiotics KW - Sacchromyces boullardi KW - Synbiotics KW - VSL#3 SP - 81 EP - 8 JF - Best practice & research. Clinical gastroenterology JO - Best Pract Res Clin Gastroenterol VL - 30 IS - 1 N2 - Therapeutic manipulation of gut microbiota has proven valuable in the management of ulcerative colitis and pouchitis. Despite some similarities among the various inflammatory bowel conditions, the probiotics investigated thus far seem to confer little benefit in Crohn's disease. In this review, we aim to bring together the evidence available on the clinical effect of probiotics and prebioltics in Crohn's disease patients, and to clarify the place of probiotic treatment in current Crohn's therapeutic regimens. SN - 1532-1916 UR - https://www.unboundmedicine.com/medline/citation/27048899/Probiotics_and_prebiotics_in_Crohn's_disease_therapies_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1521-6918(16)00006-8 DB - PRIME DP - Unbound Medicine ER -